Heartbeam Inc 's Cash & cash equivalent grew by 326.68 % in the Q2 2026 sequentially, while Current Liabilities decreased, this led to improvement in Heartbeam Inc 's Quick Ratio to 3.54, Quick Ratio remained below Heartbeam Inc average.

Within Medical Equipment & Supplies industry 49 other companies have achieved higher Quick Ratio than Heartbeam Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 2098 to 2470.

Explain Quick Ratio?
How much Cash & cash equivalents BEAT�s has?
What are BEAT�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BEAT Quick Ratio	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3	(Jun 30 2025) Q2
Y / Y Current Liabilities Change	36.74 %	108.75 %	99.75 %	33.08 %	26.69 %
Y / Y Cash & cash equivalent Change	167.2 %	-53.55 %	84.27 %	-67.82 %	-64.44 %
Quick Ratio MRQ	3.54	0.62	1.35	0.75	1.81
BEAT's Total Ranking	# 2470	# 2098	# 2602	# 1696	# 1352
Seq. Current Liabilities Change	-25.32 %	1.67 %	31.17 %	37.3 %	14.01 %
Seq. Cash & cash equivalent Change	326.68 %	-53.45 %	135.99 %	-43 %	-25.83 %

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 50
Healthcare Sector	# 371
Overall Market	# 998

Quick Ratio Statistics
High	Average	Low
30.53	3.91	0.01
(Jun 30 2023)		(Dec 31 2020)

Financial Statements
Heartbeam Inc 's Current Liabilities	$ 2 Millions	Visit BEAT's Balance sheet
Heartbeam Inc 's Cash & cash equivalent	$ 9 Millions	Visit BEAT's Balance sheet
Source of BEAT's Sales		Visit BEAT's Sales by Geography

Cumulative Heartbeam Inc 's Quick Ratio

BEAT's Quick Ratio for the trailling 12 Months

BEAT Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	67.24 %	66.82 %	51.58 %	51.53 %	67.52 %
Y / Y Cash & cash equivalent TTM Growth	7.5 %	-46.84 %	-53.63 %	-72.85 %	-72.38 %
Quick Ratio TTM	1.48	1.07	1.53	1.59	2.3
Total Ranking TTM	# 1235	# 1068	# 2602	# 1696	# 1352
Seq. Current Liabilities TTM Growth	6.12 %	18.88 %	21.66 %	8.96 %	5.85 %
Seq. Cash & cash equivalent TTM Growth	47.21 %	-16.94 %	16.86 %	-24.77 %	-27.2 %

Quick ratio ranking by company, industry and sector >> Back to BEAT Financial Strength Comparisons >> Go to Compare BEAT Quick Ratio to its Competitors

On the trailing twelve months basis BEAT Cash & cash equivalent more than doubled by 167.2 % in Q2 2026 year on year, faster than Current Liabilities, this led to increase in in Heartbeam Inc 's Quick Ratio to 1.48, above BEAT average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 200 other companies have achieved higher Quick Ratio than Heartbeam Inc . While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending first quarter 2026 at 3971.

Explain Quick Ratio?
How much Cash & cash equivalents BEAT�s has?
What are BEAT�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 201
Healthcare Sector	# 885
Within the Market	# 2470

trailing twelve months Quick Ratio Statistics
High	Average	Low
4.3	1.06	0.43
(Jun 30 2022)		(Dec 31 2014)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Pulse Biosciences Inc	9.26	$ 101.620 Millions	$ 10.978 Millions
Orchestra Biomed Holdings Inc	8.16	$ 109.963 Millions	$ 13.471 Millions
Biolife Solutions Inc	8.11	$ 113.100 Millions	$ 13.947 Millions
Bone Biologics Corporation	7.87	$ 4.032 Millions	$ 0.512 Millions
Beyond Air Inc	7.68	$ 26.340 Millions	$ 3.428 Millions
Talkspace Inc	7.62	$ 90.998 Millions	$ 11.937 Millions
Safe Pro Group Inc	7.24	$ 10.231 Millions	$ 1.413 Millions
Delcath Systems Inc	7.22	$ 95.902 Millions	$ 13.279 Millions
Streamex Corp	7.16	$ 18.586 Millions	$ 2.595 Millions
Endra Life Sciences Inc	7.04	$ 5.540 Millions	$ 0.787 Millions
Iradimed Corporation	6.45	$ 59.080 Millions	$ 9.164 Millions
Orasure Technologies Inc	6.39	$ 160.582 Millions	$ 25.119 Millions
Alpha Pro Tech Ltd	5.94	$ 18.901 Millions	$ 3.180 Millions
Si bone inc	5.89	$ 141.519 Millions	$ 24.042 Millions
Dexcom Inc	5.84	$ 1,107.000 Millions	$ 189.500 Millions
Cvrx inc	5.78	$ 64.586 Millions	$ 11.177 Millions
Carlsmed Inc	5.67	$ 70.244 Millions	$ 12.397 Millions
Profound Medical Corp	5.24	$ 38.271 Millions	$ 7.304 Millions
Rxsight Inc	5.03	$ 404.247 Millions	$ 80.444 Millions
Transmedics Group Inc	4.81	$ 472.675 Millions	$ 98.283 Millions
Aethlon Medical Inc	4.76	$ 4.934 Millions	$ 1.036 Millions
Bluejay Diagnostics Inc	4.53	$ 9.599 Millions	$ 2.117 Millions
Hyperfine Inc	4.51	$ 43.458 Millions	$ 9.629 Millions
Innovative Eyewear Inc	4.36	$ 2.455 Millions	$ 0.563 Millions
Autonomix Medical Inc	4.23	$ 3.460 Millions	$ 0.818 Millions
Sharps Technology Inc	4.16	$ 12.071 Millions	$ 2.903 Millions
Trisalus Life Sciences Inc	4.14	$ 46.288 Millions	$ 11.172 Millions
Kestra Medical Technologies Ltd	4.12	$ 198.911 Millions	$ 48.269 Millions
Sight Sciences Inc	3.89	$ 79.753 Millions	$ 20.499 Millions
Irhythm Holdings Inc	3.82	$ 839.951 Millions	$ 219.981 Millions

Date modified: 2026-09-08T16:45:50+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.